A detailed history of Israel Englander (Millennium Management LLC) transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Millennium Management LLC holds 11,952 shares of HBIO stock, worth $25,816. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,952
Previous 148,422 91.95%
Holding current value
$25,816
Previous $423,000 92.43%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.64 - $3.54 $360,280 - $483,103
-136,470 Reduced 91.95%
11,952 $32,000
Q2 2024

Aug 14, 2024

BUY
$2.77 - $4.63 $358,584 - $599,367
129,453 Added 682.45%
148,422 $423,000
Q1 2024

May 15, 2024

SELL
$4.02 - $5.39 $176,502 - $236,653
-43,906 Reduced 69.83%
18,969 $80,000
Q4 2023

Feb 14, 2024

SELL
$4.0 - $5.49 $811,100 - $1.11 Million
-202,775 Reduced 76.33%
62,875 $336,000
Q2 2023

Aug 14, 2023

BUY
$4.19 - $6.16 $554,232 - $814,814
132,275 Added 99.18%
265,650 $1.46 Million
Q1 2023

May 15, 2023

SELL
$2.45 - $4.22 $75,594 - $130,208
-30,855 Reduced 18.79%
133,375 $560,000
Q4 2022

Feb 14, 2023

SELL
$2.12 - $2.86 $87,931 - $118,624
-41,477 Reduced 20.16%
164,230 $455,000
Q3 2022

Nov 14, 2022

SELL
$2.33 - $3.92 $431,653 - $726,215
-185,259 Reduced 47.38%
205,707 $527,000
Q2 2022

Aug 15, 2022

BUY
$3.28 - $6.42 $1.03 Million - $2.02 Million
314,413 Added 410.71%
390,966 $1.41 Million
Q1 2022

May 16, 2022

SELL
$5.16 - $7.14 $86,662 - $119,916
-16,795 Reduced 17.99%
76,553 $475,000
Q4 2021

Feb 14, 2022

SELL
$6.37 - $8.18 $305,142 - $391,846
-47,903 Reduced 33.91%
93,348 $658,000
Q3 2021

Nov 15, 2021

SELL
$6.98 - $8.47 $30,090 - $36,514
-4,311 Reduced 2.96%
141,251 $986,000
Q2 2021

Aug 16, 2021

BUY
$5.44 - $8.4 $468,155 - $722,887
86,058 Added 144.63%
145,562 $1.21 Million
Q1 2021

May 17, 2021

BUY
$3.91 - $6.99 $166,253 - $297,214
42,520 Added 250.35%
59,504 $325,000
Q4 2020

Feb 16, 2021

SELL
$3.0 - $4.5 $105,396 - $158,094
-35,132 Reduced 67.41%
16,984 $73,000
Q3 2020

Nov 16, 2020

BUY
$2.75 - $4.2 $9,047 - $13,818
3,290 Added 6.74%
52,116 $157,000
Q2 2020

Aug 14, 2020

SELL
$2.12 - $3.14 $1.03 Million - $1.53 Million
-486,400 Reduced 90.88%
48,826 $151,000
Q1 2020

May 14, 2020

BUY
$1.42 - $3.29 $36,505 - $84,579
25,708 Added 5.05%
535,226 $1.18 Million
Q4 2019

Feb 14, 2020

SELL
$2.45 - $3.25 $332,741 - $441,392
-135,813 Reduced 21.05%
509,518 $1.55 Million
Q3 2019

Nov 14, 2019

SELL
$1.59 - $3.47 $670,989 - $1.46 Million
-422,006 Reduced 39.54%
645,331 $1.98 Million
Q2 2019

Aug 15, 2019

BUY
$1.93 - $4.59 $1.94 Million - $4.63 Million
1,007,707 Added 1689.93%
1,067,337 $2.14 Million
Q2 2019

Aug 14, 2019

SELL
$1.93 - $4.59 $30,117 - $71,626
-15,605 Reduced 20.74%
59,630 $1.06 Million
Q1 2019

May 14, 2019

BUY
$2.77 - $4.38 $158,335 - $250,365
57,161 Added 316.26%
75,235 $324,000
Q4 2018

Feb 14, 2019

SELL
$3.03 - $5.0 $307,093 - $506,755
-101,351 Reduced 84.87%
18,074 $57,000
Q3 2018

Nov 14, 2018

BUY
$5.0 - $6.65 $295,360 - $392,828
59,072 Added 97.88%
119,425 $627,000
Q2 2018

Aug 14, 2018

SELL
$4.2 - $5.95 $694,117 - $983,332
-165,266 Reduced 73.25%
60,353 $323,000
Q1 2018

May 15, 2018

BUY
$3.3 - $5.15 $673,721 - $1.05 Million
204,158 Added 951.3%
225,619 $1.13 Million
Q4 2017

Feb 14, 2018

SELL
$3.08 - $3.8 $100,922 - $124,514
-32,767 Reduced 60.42%
21,461 $71,000
Q3 2017

Nov 14, 2017

BUY
$2.7 - $3.75 $146,415 - $203,355
54,228
54,228 $203,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.9M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.